Improving participation in cancer clinical trials at UPMC Hillman Cancer Center
NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
This study is working to make it easier for patients with rare cancers and specific genetic traits to join late-phase clinical trials at UPMC Hillman Cancer Center, especially for those from minority and rural communities, so they can access the latest cancer treatments while helping new researchers learn how to run these trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10786043 on NIH RePORTER |
What this research studies
This research aims to enhance the involvement of UPMC Hillman Cancer Center in late-phase clinical trials for cancer treatment. It focuses on improving the processes for activating new trials, particularly for rare cancers and specific genetic subpopulations. The project also emphasizes increasing participation from minority and rural populations, while providing mentorship to junior investigators in conducting these trials. Patients may benefit from improved access to cutting-edge cancer treatments and therapies through these trials.
Who could benefit from this research
Good fit: Ideal candidates for participation include adults aged 21 and older who are diagnosed with cancer, particularly those from minority or rural backgrounds.
Not a fit: Patients who are not diagnosed with cancer or are under 21 years old may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with better access to innovative cancer treatments and improve outcomes through participation in clinical trials.
How similar studies have performed: Previous research has shown success in enhancing clinical trial participation and outcomes through similar initiatives in other academic medical centers.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Brufsky, Adam M — University of Pittsburgh at Pittsburgh
- Study coordinator: Brufsky, Adam M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.